首页> 外文期刊>Mediterranean Journal of Hematology and Infectious Diseases >Adjuvant corticosteroid therapy in hepatosplenic candidiasis-related IRIS
【24h】

Adjuvant corticosteroid therapy in hepatosplenic candidiasis-related IRIS

机译:肝脾念珠菌病相关的IRIS辅助糖皮质激素治疗

获取原文
           

摘要

Hepatosplenic candidiasis (HSC) is a form of invasive fungal infection that occurs most commonly in patients with acute leukemia treated with chemotherapy and requires protracted antifungal therapy. Immune reconstitution inflammatory syndrome (IRIS) is best characterized as a dysregulated inflammatory responses triggered by rapid resolution of immunosuppression. We present a child diagnosed with standard-risk precursor B cell-acute lymphoblastic leukemia who developed HSC and Candida-related IRIS during recovery of neutropenia associated with induction chemotherapy. Addition of corticosteroid therapy to antifungal treatment is associated with the resolution of the clinical symptoms and laboratory findings
机译:肝脾念珠菌病(HSC)是一种侵袭性真菌感染,最常发生在接受化学疗法治疗的急性白血病患者中,需要长期的抗真菌治疗。免疫重建性炎症综合症(IRIS)的最佳特征是免疫抑制的快速解决引发的炎症反应失调。我们介绍了一个被诊断为具有标准风险的前体B细胞急性淋巴细胞白血病的儿童,该儿童在与诱导化疗相关的中性粒细胞减少的恢复过程中发生了HSC和念珠菌相关的IRIS。在抗真菌治疗中增加糖皮质激素治疗与临床症状和实验室检查结果的缓解有关

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号